We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

143 hedge funds and large institutions have $212M invested in Viking Therapeutics in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $4.78M | Put options by funds: $2.87M

18% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 17

2% more funds holding

Funds holding: 140 → 143 (+3)

2.64% less ownership

Funds ownership: 54.37% → 51.73% (-2.6%)

8% less capital invested

Capital invested by funds: $230M → $212M (-$17.6M)

12% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 50

Holders
143
Holders Change
+3
Holders Change %
+2.14%
% of All Funds
2.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
44
Reduced
50
Closed
17
Calls
$4.78M
Puts
$2.87M
Net Calls
+$1.91M
Net Calls Change
-$3.6M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.67M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$3.14M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$2.31M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.37M
5
Group One Trading
Group One Trading
Illinois
+$1.14M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.69M
2
Goldman Sachs
Goldman Sachs
New York
-$3.31M
3
DM
Deerfield Management
New York
-$2.03M
4
Morgan Stanley
Morgan Stanley
New York
-$1.55M
5
UBS Group
UBS Group
Switzerland
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
FHA
126
First Horizon Advisors
Tennessee
$4K – – –
MA
127
Montag & Associates
Georgia
$4K +$3.94K +650 New
VFA
128
Valeo Financial Advisors
Indiana
$4K +$4.3K +710 New
ASN
129
Advisory Services Network
Georgia
$3K -$24 -4 -0.8%
CFD
130
Creative Financial Designs
Indiana
$3K – – –
Federated Hermes
131
Federated Hermes
Pennsylvania
$3K +$1.02K +168 +48%
TWA
132
TCI Wealth Advisors
Arizona
$2K -$606 -100 -20%
Rockefeller Capital Management
133
Rockefeller Capital Management
New York
$2K – – –
SSB
134
Sandy Spring Bank
Maryland
$2K +$2.06K +340 New
ICP
135
Interchange Capital Partners
Pennsylvania
$2K +$2.94K +486 New
GWM
136
Geneos Wealth Management
Colorado
$2K +$12K +1,975 +527%
FIA
137
FNY Investment Advisers
New York
$1K – – –
S
138
SignatureFD
Georgia
$1K +$1.16K +191 New
AIG
139
American International Group
New York
$215 -$6.62K -1,093 -3%
Fidelity Investments
140
Fidelity Investments
Massachusetts
– -$9.69M -1,600,004 -100%
DM
141
Deerfield Management
New York
– -$2.03M -348,441 Closed
LSA
142
L & S Advisors
California
– -$669K -114,988 Closed
WC
143
Woodstock Corp
Massachusetts
– -$426K -73,151 Closed
PP
144
PDT Partners
New York
– -$281K -48,294 Closed
B
145
Bailard
California
– -$272K -46,720 Closed
Millennium Management
146
Millennium Management
New York
– -$204 -35,091 Closed
SFI
147
Susquehanna Fundamental Investments
Pennsylvania
– -$116K -20,000 Closed
HR
148
Hayden Royal
North Carolina
– -$114K -19,675 Closed
HighTower Advisors
149
HighTower Advisors
Illinois
– -$62K -10,601 Closed
MAM
150
Meeder Asset Management
Ohio
– -$53K -9,258 Closed
3 4 5
6
7

VKTX Hedge Fund Activity: Q4 2020 in Review

143 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q4 2020, worth a combined $212M — down 7.7% from $230M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VKTX positions and 17 closed out — a net gain of 3 holders — while 44 added to existing stakes and 50 trimmed.

The largest buyer was BlackRock, adding an estimated $3.67M. The largest seller was Fidelity Investments, cutting an estimated $9.69M.

  • 143 institutional investors held Viking Therapeutics (VKTX) as of Q4 2020, up from 140 in Q3 2020.
  • Funds reported $212M of Viking Therapeutics stock for Q4 2020, down 7.7% quarter-over-quarter.
  • 20 funds opened new Viking Therapeutics positions in Q4 2020 and 17 closed out, a net change of +3 holders.
  • The largest Viking Therapeutics buyer in Q4 2020 was BlackRock, an estimated $3.67M added.
  • The largest Viking Therapeutics seller in Q4 2020 was Fidelity Investments, an estimated $9.69M sold.

Based on aggregated 13F filings for Q4 2020.